EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.

ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California, adding a manufacturing function...
Continue Reading →
Europe

Clinical research thrives in the UK, figures show

Health research is thriving in the UK with more people taking part in NHS clinical research than ever before, new figures from the National Institute for Health Res...
Continue Reading →
Europe

Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus

Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to deve...
Continue Reading →
Asia Pacific

CStone’s PD-1 inhibitor CS1003 gets clinical trial approval in China

CStone will initiate a multi-center Phase I clinical trial to assess the safety, tolerability and preliminary anti-tumor activity of CS1003 in Chinese patients with a...
Continue Reading →
Europe

SQN Clinical Launches the Most Advanced Real-time Analytics Tool for Clinical Research

SQN Clinical launches SQN Health Analytics, providing clinical professionals with a clear picture of the entire trial process and all collected data, whenever and whe...
Continue Reading →
Europe

Aeromics Initiates Phase 1 Clinical Trial Of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers

Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema for people affected by dis...
Continue Reading →
Europe

Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer

Virginia Borges, MD, MMSc, Phase 1b clinical trial results published in JAMA Oncology show pr...
Continue Reading →
Europe

OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer

Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a...
Continue Reading →
Europe

Atlantic Health System enrolling patients in pancreatic cancer clinical trials

Angela Alistar, M.D., director of GI medical oncology at the Carol G. Simon Cancer Center of Morristown Medical Center,...
Continue Reading →
Europe

Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment

Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing nove...
Continue Reading →
Catalyst: 12th January 2026
Quotient